Results 61 to 70 of about 9,997 (164)
Rivastigmine for the treatment of dementia associated with Parkinson’s disease
Neuropsychiatric Disease and Treatment, 2007 Jennifer L Reingold, John C Morgan, Kapil D SethiMovement Disorders Program, Department of Neurology, Medical College of Georgia, Augusta, GA, USAAbstract: Parkinson’s disease (PD) afflicts millions of people worldwide and leads to cognitive ...
Jennifer L Reingold +2 more
doaj
Tijdschrift voor Gerontologie en GeriatrieCasusbespreking van drie patie¨nten opgenomen in verband met hallucinaties bij de ziekte van Parkinson zonder dementie waarbij naast aanpassing van de anti-parkinson medicatie tevens wordt gestart met rivastigmine waardoor hallucinaties verdwenen en ...
jmp Rovers +2 more
doaj +1 more source
Clinical Interventions in Aging, 2017 Nagaendran Kandiah,1,2 Ming-Chyi Pai,3,4 Vorapun Senanarong,5 Irene Looi,6,7 Encarnita Ampil,8 Kyung Won Park,9 Ananda Krishna Karanam,10 Stephen Christopher11 1Department of Neurology, National Neuroscience Institute, Tan Tock Seng Hospital, 2Duke-NUS,
Kandiah N +7 more
doaj
Dementia & NeuropsychologiaThere is not much published literature on the use of rivastigmine patch in a "routine" clinical setting. Objectives: In this naturalistic longitudinal observational study we sought to evaluate the safety, tolerability and efficacy of the rivastigmine ...
Ejaz Nazir, Muhammad Mushtaq
doaj +1 more source
Neuropsychiatric Disease and Treatment, 2012 Johannes Seibert1, Ferenc Tracik2,3, Konstantin Articus2, Stefan Spittler41Outpatient Clinic, Heidelberg, Germany; 2Novartis Pharma, Nürnberg, Germany; 3Department of Neurology, Heinrich-Heine University, Düsseldorf, Germany; 4Alexianer
Seibert J +3 more
doaj
Adverse drug events affecting medication persistence with rivastigmine patch application
Patient Preference and Adherence, 2018 Takashi Osada,1 Norio Watanabe,1 Naomitsu Asano,2 Yuzo Adachi,2 Keiko Yamamura1 1Clinical Pharmacy, School of Pharmacy, Aichi Gakuin University, Nagoya, Aichi, Japan; 2Sasayuri Pharmacy, Toki, Gifu, Japan Purpose: The rivastigmine transdermal patch ...
Osada T +4 more
doaj
Brain CirculationBACKGROUND: Acetylcholinesterase inhibitors (AChEIs) are widely used in Alzheimer’s disease (AD). This study aims to systematically review the literature about movement disorders (MDs) associated with AChEIs for AD, which include donepezil, galantamine ...
Jamir Pitton Rissardo +1 more
doaj +1 more source
Determination of Alzheimer’s Drugs in a Human Urine Sample by Different Chemometric Methods
International Journal of Analytical ChemistryIn this study, spectrophotometric determination of donepezil and rivastigmine in healthy human urine samples was carried out by the statistical method.
Güzide Pekcan
doaj +1 more source
Skin Lesions as Signs of Neuroenhancement in Sport
Brain SciencesBackground: Neuroenhancement in sports, through pharmacological and non-pharmacological methods, is a complex and highly debated topic with no definitive regulatory framework established by the World Anti-Doping Agency (WADA).
Sorana-Cristiana Popescu +3 more
doaj +1 more source